Cargando…
Treatment of Indolent Cutaneous B-Cell Lymphoma with Intralesional or Intravenous Rituximab
SIMPLE SUMMARY: Cutaneous B-cell lymphomas (CBCL) are a heterogeneous group of mature B-cells neoplasms that present in the skin without evidence of nodal or systemic involvement. Despite being indolent in nature, they tend to recur in a third of patients after treatment. As repetitive treatments ma...
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
MDPI
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9564090/ https://www.ncbi.nlm.nih.gov/pubmed/36230709 http://dx.doi.org/10.3390/cancers14194787 |